Form 4 for ABOS Acumen Pharmaceuticals, Inc.
Accepted 2023-08-18 00:00:00 ET · period of report 2023-08-17 · accession 0001576885-23-000052 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-08-18 | 2023-08-17 | ABOS | Ives Jeffrey L. | Dir | S - Sale+OE | $6.49 | -41.9K | 0 | -100% | -$272.3K |
| DM | 2023-08-18 | 2023-08-17 | ABOS | Ives Jeffrey L. | Dir | M - OptEx | $0.7514 | +41.9K | 2,800 | New | +$31.5K |
| DM | 2023-08-18 | 2023-08-17 | ABOS | Ives Jeffrey L. | Dir | M - OptEx | $0.00 | -41.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-17 | S | D | 39,149 | $6.48 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-17 | S | D | 2,800 | $6.66 | 0 | D | — | — | |
| 3 | Common | Common Stock | 2023-08-17 | M | A | 39,149 | $0.72 | 39,149 | D | — | — | |
| 4 | Common | Common Stock | 2023-08-17 | M | A | 2,800 | $1.19 | 2,800 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2023-08-17 | M | D | 39,149 | $0.00 | 0 | D | $0.72 · — to 2029-03-01 | 39,149 Common Stock | (F2) The option is fully vested. |
| 6 | Derivative | Stock Option (right to buy) | 2023-08-17 | M | D | 2,800 | $0.00 | 0 | D | $1.19 · — to 2031-01-03 | 2,800 Common Stock | (F2) The option is fully vested. |